These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24293047)

  • 21. Left atrial dilatation and ST-T changes predict cardiovascular outcome in chronic hemodialysis patients.
    Omae K; Ogawa T; Yoshikawa M; Nitta K
    Heart Vessels; 2012 Nov; 27(6):610-7. PubMed ID: 21953505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved blood pressure and left ventricular remodelling in children on chronic intermittent haemodialysis: a longitudinal study.
    Melhem N; Savis A; Wheatley A; Copeman H; Willmott K; Reid CJD; Simpson J; Sinha MD
    Pediatr Nephrol; 2019 Oct; 34(10):1811-1820. PubMed ID: 31098707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor-23 and cardiac structure and function.
    Agarwal I; Ide N; Ix JH; Kestenbaum B; Lanske B; Schiller NB; Whooley MA; Mukamal KJ
    J Am Heart Assoc; 2014 Feb; 3(1):e000584. PubMed ID: 24525546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?
    Gunal AI; Kirciman E; Guler M; Yavuzkir M; Celiker H
    Ren Fail; 2004 Jul; 26(4):405-9. PubMed ID: 15462109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender differences in mediators of left ventricular hypertrophy in dialysis patients.
    Savage T; Giles M; Tomson CV; Raine AE
    Clin Nephrol; 1998 Feb; 49(2):107-12. PubMed ID: 9524781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens.
    Wang MC; Tseng CC; Tsai WC; Huang JJ
    Perit Dial Int; 2001; 21(1):36-42. PubMed ID: 11280494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
    Smith K; deFilippi C; Isakova T; Gutiérrez OM; Laliberte K; Seliger S; Kelley W; Duh SH; Hise M; Christenson R; Wolf M; Januzzi J
    Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between different blood pressure measurements and left ventricular mass by cardiac magnetic resonance imaging in end-stage renal disease.
    Merchant A; Wald R; Goldstein MB; Yuen D; Kirpalani A; Dacouris N; Ray JG; Kiaii M; Leipsic J; Kotha V; Deva D; Yan AT
    J Am Soc Hypertens; 2015 Apr; 9(4):275-84. PubMed ID: 25753299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategy for Prevention of Left Ventricular Remodeling in Predialysis and Dialysis Patients.
    Io H; Suzuki Y
    Contrib Nephrol; 2018; 196():13-21. PubMed ID: 30041199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study.
    Peteiro J; Alvarez N; Calviño R; Penas M; Ribera F; Castro Beiras A
    Cardiology; 1994; 85(5):273-83. PubMed ID: 7850816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction.
    Nielsen TL; Plesner LL; Warming PE; Mortensen OH; Iversen KK; Heaf JG
    Nefrologia (Engl Ed); 2019; 39(3):258-268. PubMed ID: 30723045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indexation of left ventricular mass to predict adverse clinical outcomes in pre-dialysis patients with chronic kidney disease: KoreaN cohort study of the outcome in patients with chronic kidney disease.
    Lee SW; Min HK; Chae DW; Oh KH; Ahn C; Chung W; Lee J; Kim YS; Sung SA;
    PLoS One; 2020; 15(5):e0233310. PubMed ID: 32428014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients.
    Monfared A; Salari A; Kazemnezhad E; Lebadi M; Khosravi M; Mehrjardi NK; Rahimifar S; Amini N
    Int Urol Nephrol; 2013 Dec; 45(6):1679-86. PubMed ID: 23306861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients.
    Nohara N; Io H; Matsumoto M; Furukawa M; Okumura K; Nakata J; Shimizu Y; Horikoshi S; Tomino Y
    Clin Exp Nephrol; 2016 Oct; 20(5):740-747. PubMed ID: 26707759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.
    Chan CT; Greene T; Chertow GM; Kliger AS; Stokes JB; Beck GJ; Daugirdas JT; Kotanko P; Larive B; Levin NW; Mehta RL; Rocco M; Sanz J; Yang PC; Rajagopalan S;
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2106-16. PubMed ID: 23970131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.
    Hsu HJ; Wu MS
    Am J Med Sci; 2009 Feb; 337(2):116-22. PubMed ID: 19214027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease.
    Foley RN; Curtis BM; Randell EW; Parfrey PS
    Clin J Am Soc Nephrol; 2010 May; 5(5):805-13. PubMed ID: 20378644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between serum uric acid and left ventricular hypertrophy/left ventricular diastolic dysfunction in patients with chronic kidney disease.
    Kim IY; Ye BM; Kim MJ; Kim SR; Lee DW; Kim HJ; Rhee H; Song SH; Seong EY; Lee SB
    PLoS One; 2021; 16(5):e0251333. PubMed ID: 33956863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
    Mirza MA; Larsson A; Melhus H; Lind L; Larsson TE
    Atherosclerosis; 2009 Dec; 207(2):546-51. PubMed ID: 19524924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.